PAR 4.26% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3420

  1. 515 Posts.
    lightbulb Created with Sketch. 43
    “Unapproved injectable formulations of pentosan have a long history of use in horses, but the newly approved therapy is the first injectable pentosan product to have met the FDA’s standards. FDA-approved drugs have been demonstrated to be safe and effective for their intended use and have been consistently manufactured to preserve the drugs’ identity, strength, quality, and purity. The FDA is strongly encouraging veterinarians to use the legally marketed FDA-approved pentosan polysulfate sodium injection when pentosan is indicated for use in an equine patient.”
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.010(4.26%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.0¢ 25.5¢ 24.0¢ $45.29K 184.5K

Buyers (Bids)

No. Vol. Price($)
10 85695 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 40402 12
View Market Depth
Last trade - 13.51pm 12/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.